Published in BMC Cardiovasc Disord on August 18, 2004
Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract (2008) 1.32
Primary-care clinician perceptions of racial disparities in diabetes care. J Gen Intern Med (2008) 1.18
Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk. Prev Cardiol (2009) 1.09
Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res (2007) 1.00
Racial and geographic differences in prevalence, awareness, treatment and control of dyslipidemia: the reasons for geographic and racial differences in stroke (REGARDS) study. Neuroepidemiology (2011) 0.86
Multiple measurement of serum lipids in the elderly. Med Care (2011) 0.82
Racial disparities in lipid control in patients with diabetes. Am J Manag Care (2012) 0.82
What is the impact of physician communication and patient understanding in the management of headache? Neuropsychiatr Dis Treat (2007) 0.75
Models for longitudinal data: a generalized estimating equation approach. Biometrics (1988) 27.90
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Improving chronic illness care: translating evidence into action. Health Aff (Millwood) (2001) 22.31
Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract (1999) 16.57
Race, gender, and partnership in the patient-physician relationship. JAMA (1999) 13.80
Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation (1993) 11.57
The case for more active policy attention to health promotion. Health Aff (Millwood) (2002) 8.03
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care (1997) 7.85
Race and trust in the health care system. Public Health Rep (2003) 6.74
Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels. JAMA (2000) 6.10
Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation (2003) 3.39
National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation (1994) 2.94
What the federal government can do about the nonmedical determinants of health. Health Aff (Millwood) (2002) 1.91
Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med (2002) 1.78
Diabetes in the African-American Medicare population. Morbidity, quality of care, and resource utilization. Diabetes Care (1998) 1.74
Recent trends in the identification and treatment of high blood cholesterol by physicians. Progress and missed opportunities. JAMA (1993) 1.69
Lipid testing among patients with diabetes who receive diabetes care from primary care physicians. Diabetes Care (2003) 1.52
Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med (1998) 1.42
Variations in cholesterol management practices of U.S. physicians. J Am Coll Cardiol (1997) 1.42
Racial and ethnic disparity in blood pressure and cholesterol measurement. J Gen Intern Med (2002) 1.20
Disparities in use of lipid-lowering medications among people with type 2 diabetes mellitus. Arch Intern Med (2003) 1.20
Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines. J Gen Intern Med (2001) 1.14
Physician explanations for failing to comply with "best practices". Eff Clin Pract (2001) 1.11
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care (2003) 1.01
Disparities in cholesterol screening: falling short of a national health objective. Prev Med (2001) 1.00
Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center. Ethn Dis (2002) 0.99
Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction. J Gen Intern Med (2002) 0.98
How cost-effective are new preventive strategies for cardiovascular disease? Am J Cardiol (2003) 0.95
Development and validation of the hyperlipidemia: attitudes and beliefs in treatment (HABIT) survey for physicians. J Gen Intern Med (2003) 0.91
Underutilization of lipid-lowering drugs in older persons with prior myocardial infarction and a serum low-density lipoprotein cholesterol > 125 mg/dl. Am J Cardiol (1998) 0.90
Lipid management among coronary artery disease patients with diabetes mellitus or advanced age. Am J Cardiol (2001) 0.89
Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure. J Card Fail (2003) 0.89
Effectiveness of the electronic medical record in cholesterol management in patients with coronary artery disease (Virtual Lipid Clinic). Am J Cardiol (2001) 0.87
Powerlessness, destiny, and control: the influence on health behaviors of African Americans. J Community Health (2004) 0.85
Unequal access: African-American Medicare beneficiaries and the prescription drug gap. Issue Brief Cent Stud Health Syst Change (2003) 0.85
Cholesterol-related knowledge, attitudes, and behaviors in a low-income, urban patient population. Am J Prev Med (1994) 0.83
The low-density lipoprotein cholesterol-lowering effect of pravastatin and factors associated with achieving targeted low-density lipoprotein levels in an African-American population. Pharmacotherapy (2000) 0.82
Effects of race on lipid-lowering management in hospitalized patients with coronary heart disease. Am J Cardiol (2004) 0.82
Disparity between whites and african-americans in knowledge and treatment of cholesterol. Carolina heart survey. Ann Epidemiol (2000) 0.81
Population implications of changes in lipid management in patients with coronary heart disease. Am J Cardiol (2004) 0.81
Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction. Am J Cardiol (1997) 0.81
Trends in lipid management among patients with coronary artery disease: has diabetes received the attention it deserves? Diabetes Care (2003) 0.81
Educational level has a major impact on the representations of cholesterol: a study in 1579 hypercholesterolemic patients. Prev Med (2004) 0.76
A heart failure self-management program for patients of all literacy levels: a randomized, controlled trial [ISRCTN11535170]. BMC Health Serv Res (2006) 2.88
Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol (2003) 2.06
Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care (2003) 1.91
Premature ventricular complexes and the risk of incident stroke: the Atherosclerosis Risk In Communities (ARIC) Study. Stroke (2010) 1.82
Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care (2005) 1.81
Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med (2014) 1.78
Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Clin Infect Dis (2005) 1.76
Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort). Am J Cardiol (2006) 1.70
Health care cost associated with prostate cancer, androgen deprivation therapy and bone complications. J Urol (2007) 1.56
Lipid testing among patients with diabetes who receive diabetes care from primary care physicians. Diabetes Care (2003) 1.52
Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Diabetes Care (2004) 1.50
Associations of nonrestorative sleep with insomnia, depression, and daytime function. Sleep Med (2010) 1.48
The effect of cholesterol reduction with cholestyramine on renal function. Am J Kidney Dis (2005) 1.46
Survival rates are similar between African American and white patients with heart failure. Am Heart J (2003) 1.44
Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor. Am J Med (2003) 1.43
A logic model for community engagement within the Clinical and Translational Science Awards consortium: can we measure what we model? Acad Med (2013) 1.41
The coming of age of the metabolic syndrome. Diabetes Care (2003) 1.32
Cultural attitudes toward weight, diet, and physical activity among overweight African American girls. Prev Chronic Dis (2008) 1.26
Challenges for improving medication adherence. JAMA (2006) 1.18
Multisite randomized trial of a single-session versus multisession literacy-sensitive self-care intervention for patients with heart failure. Circulation (2012) 1.15
Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung (2004) 1.12
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation. Diabetes Care (2003) 1.12
Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol (2012) 1.10
A randomized trial of an intervention to improve use and adherence to effective coronary heart disease prevention strategies. BMC Health Serv Res (2011) 1.08
Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting. Diabetes Care (2005) 1.07
Simvastatin effects on skeletal muscle: study design and validity. J Am Coll Cardiol (2013) 1.06
The impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trial. BMC Health Serv Res (2006) 1.06
Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol (2011) 1.05
Contemporary analysis of secondary failure of successful sulfonylurea therapy. Endocr Pract (2007) 1.05
Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States. BMC Res Notes (2012) 1.02
Employer-paid nonmedical costs for patients with diabetes and end-stage renal disease. Prev Chronic Dis (2006) 1.02
Familial roles of older African-American women with type 2 diabetes: testing of a new multiple caregiving measure. Ethn Dis (2005) 1.01
Treatment escalation and rise in HbA1c following successful initial metformin therapy. Diabetes Care (2006) 1.01
End-stage renal disease-associated managed care costs among patients with and without diabetes. Diabetes Care (2004) 1.01
The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patients. Med Care (2006) 1.00
Mid-life African-American women with type 2 diabetes: influence on work and the multicaregiver role. Ethn Dis (2002) 1.00
Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates. BMC Womens Health (2008) 0.99
Community health ambassadors: a model for engaging community leaders to promote better health in North Carolina. J Public Health Manag Pract (2008) 0.99
Ezetimibe alone reduces low-density lipoprotein cholesterol in HIV-infected patients receiving combination antiretroviral therapy. Clin Infect Dis (2008) 0.97
Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys (2011) 0.96
Differences in resident characteristics and prevalence of urinary incontinence in nursing homes in the southeastern United States. Nurs Res (2007) 0.96
A new model for developing and executing culturally appropriate behavior modification clinical trials for African Americans. Ethn Dis (2003) 0.95
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adherence (2013) 0.94
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health Qual Life Outcomes (2009) 0.94
What "price" means when buying food: insights from a multisite qualitative study with Black Americans. Am J Public Health (2013) 0.93
Improving cardiovascular risk reduction for primary prevention--utility of lifetime risk assessment. Postgrad Med (2010) 0.92
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther (2015) 0.92
Development and validation of the hyperlipidemia: attitudes and beliefs in treatment (HABIT) survey for physicians. J Gen Intern Med (2003) 0.91
Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project. Am Heart J (2005) 0.91
Perceptions of participation in an observational epidemiologic study of cancer among African Americans. Ethn Dis (2005) 0.90
Inpatient smoking-cessation counseling and all-cause mortality among the elderly. Am J Prev Med (2004) 0.90
Treatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion. J Diabetes Sci Technol (2009) 0.89
Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure. J Card Fail (2003) 0.89
Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims. Clin Ther (2009) 0.88
Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. Circ Heart Fail (2013) 0.87
Unmet social support for healthy behaviors among overweight and obese postpartum women: results from the Active Mothers Postpartum Study. J Womens Health (Larchmt) (2011) 0.87
A checklist for ascertaining study cohorts in oncology health services research using secondary data: report of the ISPOR oncology good outcomes research practices working group. Value Health (2013) 0.86
Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease. Ren Fail (2004) 0.86
Towards a unified taxonomy of health indicators: academic health centers and communities working together to improve population health. Acad Med (2014) 0.85
Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract (2009) 0.84
Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings. Prev Chronic Dis (2005) 0.84
Dissatisfaction with body size among low-income, postpartum black women. J Obstet Gynecol Neonatal Nurs (2007) 0.84
Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina. Am J Cardiol (2004) 0.83
Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction. Curr Med Res Opin (2008) 0.83
Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf (2013) 0.82
Treating pediatric obesity in the primary care setting to prevent chronic disease: perceptions and knowledge of providers and staff. N C Med J (2012) 0.82
Orthostatic change in blood pressure and incidence of atrial fibrillation: results from a bi-ethnic population based study. PLoS One (2013) 0.82
Prevalence and care of diabetes mellitus in the Medicare population of North Carolina. Baseline findings from the Medicare Healthcare Quality Improvement Program. N C Med J (2003) 0.81
Trends in lipid management among patients with coronary artery disease: has diabetes received the attention it deserves? Diabetes Care (2003) 0.81
Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes. BMC Endocr Disord (2012) 0.81
Validation of Medicaid Claims-based Diagnosis of Myocardial Infarction Using an HIV Clinical Cohort. Med Care (2015) 0.81
Effects of combination antiretroviral therapies on the risk of myocardial infarction among HIV patients. Epidemiology (2014) 0.81
Population implications of changes in lipid management in patients with coronary heart disease. Am J Cardiol (2004) 0.81
Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: comparison of predicted versus observed mortality. Diabetes Res Clin Pract (2010) 0.81
The effect of a decision aid intervention on decision making about coronary heart disease risk reduction: secondary analyses of a randomized trial. BMC Med Inform Decis Mak (2014) 0.80
Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising. J Clin Lipidol (2008) 0.80
Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices. Am J Manag Care (2002) 0.79
Beyond statins: lipid management to reduce cardiovascular risk. Pharmacotherapy (2013) 0.79
The utility of observational studies in clinical decision making: lessons learned from statin trials. Postgrad Med (2010) 0.78
The impact of losartan on the lifetime incidence of end-stage renal disease and costs in patients with type 2 diabetes and nephropathy. Pharmacoeconomics (2006) 0.78
Comparative effectiveness research for prostate cancer radiation therapy: current status and future directions. Future Oncol (2012) 0.78
The Million Hearts initiative: applying the ABCS of healthy hearts in North Carolina. N C Med J (2013) 0.78
The Hyperlipidemia: Attitudes and Beliefs in Treatment (HABIT) survey for patients: results of a validation study. J Cardiovasc Nurs (2005) 0.77
Growth in use of lipid-lowering therapies: are we targeting the right patients? Am J Manag Care (2002) 0.77
Use of the 6-minute walk test for women with diastolic heart failure. J Cardiopulm Rehabil (2004) 0.77
Trends in lipid management among patients with diabetes. Endocr Pract (2006) 0.77
Reassessment of cardiovascular risk in diabetes. Curr Opin Lipidol (2006) 0.77
Effect of angiotensin-converting inhibitor or angiotensin receptor blocker on one-year survival in patients >or=65 years hospitalized with a left ventricular ejection fraction >or=50%. Am J Cardiol (2003) 0.76
Medical devices: adapting to the comparative effectiveness landscape. Biotechnol Healthc (2010) 0.76
Illness-associated productivity costs among women with employer-sponsored insurance and newly diagnosed breast cancer. J Occup Environ Med (2010) 0.76
Effects of an accelerated intravenous iron regimen in hospitalized patients with advanced heart failure and iron deficiency. Pharmacotherapy (2014) 0.76
Heart rate variability in chronic heart failure: target for therapy? Am Heart J (2003) 0.75